Company intelligence / Profile preview

Esox Biologics

London, England, United Kingdomesoxbiologics.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Currently offering diagnostic services commercially while their pathogen-inhibiting prebiotics are still in development and not yet commercially available

Therapeutic areas: Infectious Diseases
Modalities: Feed additivesdiagnostic assays
Industry: Veterinary

Drug pipeline

1 asset

Detect

Commercial

Indications: Aquatic microbiome analysis

Beyond the preview

Go deeper on Esox Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esox Biologics.

Explore the full profile